As of March 23, 2026, the three largest insider holders of INCY are Bros. Advisors Lp Baker (Director, 28.19Mn shares), Herve Hoppenot (Director, 326.80K shares), Pablo J Cagnoni (President, Rd, 234.80K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Bros. Advisors Lp Baker | 0 | 28,188,297 | 05 Jan, 2026 | |
| Herve Hoppenot | 326,803 | 0 | 10 Dec, 2025 | |
| Pablo J Cagnoni | President, Rd | 234,800 | 0 | 23 Feb, 2026 |
| Pablo J Cagnoni | President, Rd | 234,800 | 0 | 19 Mar, 2026 |
| Christiana Stamoulis | Evp Chief Financial Officer | 125,759 | 0 | 16 Jul, 2025 |
| Paula J Swain | Evp, Human Resources | 106,482 | 0 | 16 Jul, 2025 |
| Yao Wenqing | Evp, Head Of Discovery Chem | 98,575 | 0 | 07 Jul, 2021 |
| Maria E Pasquale | Evp General Counsel | 69,724 | 0 | 18 Jul, 2023 |
| Mohamed Khairie Issa | Evp, Head Of Us Oncology | 66,132 | 0 | 08 Jan, 2026 |
| Patrick A Mayes | Evp Chief Scientific Officer | 60,011 | 0 | 12 Dec, 2025 |
| Dashyant Dhanak | Evp Chief Scientific Officer | 58,968 | 0 | 18 Jul, 2023 |
| Vijay K Iyengar | Evp, Gmapps | 40,540 | 0 | 17 Jul, 2025 |
| Lee Heeson | Evp, Head Of Incyte Intl | 38,041 | 0 | 04 Feb, 2026 |
| Jonathan Elliott Dickinson | Evp, General Manager, Europe | 36,390 | 0 | 16 Sep, 2024 |
| William Meury | Chief Executive Officer | 36,101 | 0 | 02 Jul, 2025 |
| Barry P Flannelly | Evp General Manager Us | 35,149 | 0 | 17 Jul, 2025 |
| Steven H Stein | Evp Chief Medical Officer | 34,203 | 0 | 07 Jan, 2026 |
| Michael James Morrissey | Evp, Head Of Tech. Operations | 34,065 | 0 | 04 Feb, 2026 |
| Paul Trower | Principal Accounting Officer | 32,268 | 0 | 05 Jan, 2022 |
| Sheila A. Denton | Evp General Counsel | 26,569 | 0 | 19 Nov, 2025 |
| Paul J Clancy | 23,476 | 0 | 05 Jan, 2026 | |
| Paul J Clancy | 23,476 | 0 | 05 Jan, 2026 | |
| Thomas Tray | Principal Accounting Officer | 22,973 | 0 | 22 Dec, 2025 |
| Edmund Harrigan | 20,853 | 0 | 05 Jan, 2026 | |
| Jean Jacques Bienaime | 20,841 | 0 | 12 Jun, 2025 | |
| Jean Jacques Bienaime | 20,841 | 0 | 12 Jun, 2025 | |
| Jacqualyn A Fouse | 19,326 | 0 | 12 Jun, 2025 | |
| Wendy L Dixon | 17,768 | 0 | 04 Apr, 2022 | |
| Matteo Trotta | Evp, Gm, Dermatology Us | 15,016 | 0 | 17 Jul, 2025 |
| Katherine A High | 13,341 | 0 | 12 Jun, 2025 | |
| Otis W Brawley | 11,252 | 0 | 12 Jun, 2025 | |
| Richard A. Hoffman | Evp General Counsel | 9,466 | 0 | 03 Dec, 2025 |
| David H Gardner | Evp, Chief Strategy Officer | 9,429 | 0 | 24 Sep, 2025 |
| Susanne Schaffert | 7,389 | 0 | 12 Jun, 2025 | |
| Ramitpal K Basi | Evp, Human Resources | 6,506 | 0 | 27 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Pablo J Cagnoni | Common Stock | A | 7,166 | $61.18 | 241,966 | D | M |
| 17 Mar, 2026 | Pablo J Cagnoni | Common Stock | A | 11,501 | $64.25 | 253,467 | D | M |
| 17 Mar, 2026 | Pablo J Cagnoni | Common Stock | D | 18,667 | $94.24 | 234,800 | D | S |
| 17 Mar, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 7,166 | $0.00 | 9,102 | D | M |
| 17 Mar, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 11,501 | $0.00 | 32,910 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | A | 13,093 | $61.76 | 247,893 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | A | 13,093 | $61.76 | 247,893 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | A | 5,575 | $61.18 | 253,468 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | A | 5,575 | $61.18 | 253,468 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | D | 18,668 | $100.91 | 234,800 | D | S |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | D | 18,668 | $100.91 | 234,800 | D | S |
| 19 Feb, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 13,093 | $0.00 | 7,182 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 13,093 | $0.00 | 7,182 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 5,575 | $0.00 | 16,268 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 5,575 | $0.00 | 16,268 | D | M |
| 02 Feb, 2026 | Michael James Morrissey | Common Stock | D | 185 | $102.67 | 34,065 | D | F |
| 02 Feb, 2026 | Lee Heeson | Common Stock | D | 111 | $102.67 | 38,041 | D | F |
| 16 Jan, 2026 | Thomas Tray | Employee Stock Option (right to buy) | A | 2,425 | $0.00 | 2,425 | D | A |
| 16 Jan, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | A | 28,475 | $0.00 | 28,475 | D | A |
| 16 Jan, 2026 | Steven H Stein | Employee Stock Option (right to buy) | A | 19,932 | $0.00 | 19,932 | D | A |